Search Results

There are 7921128 results for: content related to: Etiological and therapeutical observations in a case of belly dancer's dyskinesia

  1. Abstracts of The Movement Disorder Society's Twelfth International Congress of Parkinson's Disease and Movement Disorders

    Movement Disorders

    Volume 23, Issue S1, 15 May 2008, Pages: S1–S422,

    Version of Record online : 28 MAY 2008, DOI: 10.1002/mds.22133

  2. Dyskinesia Induced by Levodopa and Dopamine Agonists in Patients with Parkinson's Disease

    Drug Induced Movement Disorders, Second Edition

    John G. Nutt, Matthew A. Brodsky, Pages: 313–350, 2008

    Published Online : 14 JAN 2008, DOI: 10.1002/9780470753217.ch13

  3. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 27, Issue S1, June 2012, Pages: S1–S523,

    Version of Record online : 19 JUN 2012, DOI: 10.1002/mds.25051

  4. Clinical pattern and risk factors for dyskinesias following fetal nigral transplantation in Parkinson's disease: A double blind video-based analysis

    Movement Disorders

    Volume 24, Issue 3, 15 February 2009, Pages: 336–343, C. Warren Olanow, Jean-Michel Gracies, Christopher G. Goetz, A. Jon Stoessl, Thomas Freeman, Jeffrey H. Kordower, James Godbold and Jose A. Obeso

    Version of Record online : 12 NOV 2008, DOI: 10.1002/mds.22208

  5. Worsening of levodopa-induced dyskinesias by motor and mental tasks

    Movement Disorders

    Volume 14, Issue 2, March 1999, Pages: 242–246, Franck Durif, Marie Vidailhet, Bérangère Debilly and Yves Agid

    Version of Record online : 17 JAN 2001, DOI: 10.1002/1531-8257(199903)14:2<242::AID-MDS1007>3.0.CO;2-W

  6. A review of the assessment of dyskinesias

    Movement Disorders

    Volume 14, Issue 5, September 1999, Pages: 737–743, Jorrit I. Hoff, Bob J. van Hilten and Raymund A. C. Roos

    Version of Record online : 16 JAN 2001, DOI: 10.1002/1531-8257(199909)14:5<737::AID-MDS1005>3.0.CO;2-A

  7. Dyskinesias in Parkinsonian Syndromes

    Hyperkinetic Movement Disorders: Differential Diagnosis and Treatment

    S. Elizabeth Zauber, Christopher G. Goetz, Pages: 297–310, 2012

    Published Online : 24 FEB 2012, DOI: 10.1002/9781444346183.ch19

  8. Open-label pilot study of levetiracetam (Keppra) for the treatment of levodopa-induced dyskinesias in Parkinson's disease

    Movement Disorders

    Volume 20, Issue 9, September 2005, Pages: 1205–1209, Theresa A. Zesiewicz, Kelly L. Sullivan, John L. Maldonado, William O. Tatum and Robert A. Hauser

    Version of Record online : 13 JUN 2005, DOI: 10.1002/mds.20563

  9. Risk Factors for Dyskinesia in the Elderly

    Principles and Practice of Geriatric Psychiatry, Second Edition

    John R. M. Copeland, Mohammed T. Abou-Saleh, Dan G. Blazer, Pages: 527–533, 2002

    Published Online : 30 APR 2002, DOI: 10.1002/0470846410.ch96

  10. Parkinson's disease home diary: Further validation and implications for clinical trials

    Movement Disorders

    Volume 19, Issue 12, December 2004, Pages: 1409–1413, Robert A. Hauser, Frieda Deckers and Philippe Lehert

    Version of Record online : 21 JUL 2004, DOI: 10.1002/mds.20248

  11. Development of dyskinesias in a 5-year trial of ropinirole and L-dopa

    Movement Disorders

    Volume 21, Issue 11, November 2006, Pages: 1844–1850, Olivier Rascol, David J. Brooks, Amos D. Korczyn, Peter P. De Deyn, Carl E. Clarke, Anthony E. Lang and Mona Abdalla

    Version of Record online : 6 SEP 2006, DOI: 10.1002/mds.20988

  12. Pramipexole combined with levodopa improves motor function but reduces dyskinesia in MPTP-treated common marmosets

    Movement Disorders

    Volume 25, Issue 3, 15 February 2010, Pages: 377–384, Kayhan A. Tayarani-Binazir, Michael J. Jackson, Sarah Rose, C. Warren Olanow and Peter Jenner

    Version of Record online : 27 JAN 2010, DOI: 10.1002/mds.22960

  13. Preventing and controlling dyskinesia in Parkinson's disease—A view of current knowledge and future opportunities

    Movement Disorders

    Volume 23, Issue S3, 2008, Pages: S585–S598, Peter Jenner

    Version of Record online : 9 SEP 2008, DOI: 10.1002/mds.22022

  14. Pardoprunox reverses motor deficits but induces only mild dyskinesia in MPTP-treated common marmosets

    Movement Disorders

    Volume 25, Issue 13, 15 October 2010, Pages: 2059–2066, Louisa Clare Johnston, Michael John Jackson, Sarah Rose, Andrew Christopher McCreary and Peter Jenner

    Version of Record online : 18 AUG 2010, DOI: 10.1002/mds.23249

  15. Task force report on scales to assess dyskinesia in Parkinson's disease: Critique and recommendations

    Movement Disorders

    Volume 25, Issue 9, 15 July 2010, Pages: 1131–1142, Carlo Colosimo, Pablo Martínez-Martín, Giovanni Fabbrini, Robert A. Hauser, Marcelo Merello, Janis Miyasaki, Werner Poewe, Cristina Sampaio, Olivier Rascol, Glenn T. Stebbins, Anette Schrag and Christopher G. Goetz

    Version of Record online : 22 MAR 2010, DOI: 10.1002/mds.23072

  16. De novo administration of ropinirole and bromocriptine induces less dyskinesia than L-dopa in the MPTP-treated marmoset

    Movement Disorders

    Volume 13, Issue 2, March 1998, Pages: 234–241, Ronald K. B. Pearce, Tara Banerji, Professor Peter Jenner and C. David Marsden

    Version of Record online : 4 NOV 2004, DOI: 10.1002/mds.870130207

  17. Levodopa-dyskinesia incidence by age of Parkinson's disease onset

    Movement Disorders

    Volume 20, Issue 3, March 2005, Pages: 342–344, Neeraj Kumar, Jay A. Van Gerpen, James H. Bower and J. Eric Ahlskog

    Version of Record online : 3 DEC 2004, DOI: 10.1002/mds.20360

  18. Translation of nondopaminergic treatments for levodopa-induced dyskinesia from MPTP-lesioned nonhuman primates to phase IIa clinical studies: Keys to success and roads to failure

    Movement Disorders

    Volume 21, Issue 10, October 2006, Pages: 1578–1594, Susan H. Fox, Anthony E. Lang and Jonathan M. Brotchie

    Version of Record online : 27 JUL 2006, DOI: 10.1002/mds.20936

  19. Punding and dyskinesias

    Movement Disorders

    Volume 21, Issue 12, December 2006, Pages: 2214–2217, Laura Silveira-Moriyama, Andrew H. Evans, Regina Katzenschlager and Andrew J. Lees

    Version of Record online : 29 SEP 2006, DOI: 10.1002/mds.21118

  20. Genotype and smoking history affect risk of levodopa-induced dyskinesias in Parkinson's disease

    Movement Disorders

    Volume 21, Issue 5, May 2006, Pages: 654–659, Judith A. Strong, Arif Dalvi, Fredy J. Revilla, Alok Sahay, Frederick J. Samaha, Jeffrey A. Welge, Jianhua Gong, Maureen Gartner, Xia Yue and Lei Yu

    Version of Record online : 24 JAN 2006, DOI: 10.1002/mds.20785